Back to Search Start Over

Non-fitness status of peripheral NK cells defined by decreased NKp30 and perforin, and increased soluble B7H6, in cervical cancer patients.

Authors :
Gutierrez-Silerio GY
Bueno-Topete MR
Vega-Magaña AN
Bastidas-Ramirez BE
Gutierrez-Franco J
Escarra-Senmarti M
Pedraza-Brindis EJ
Peña-Rodriguez M
Ramos-Marquez ME
Delgado-Rizo V
Banu N
Alejandre-Gonzalez AG
Fafutis-Morris M
Haramati J
Del Toro-Arreola S
Source :
Immunology [Immunology] 2023 Mar; Vol. 168 (3), pp. 538-553. Date of Electronic Publication: 2022 Dec 27.
Publication Year :
2023

Abstract

The NKp30 receptor is one of the three natural cytotoxic receptors reported in NK cells. This receptor is codified by the NCR3 gene, which encodes three isoforms, a consequence of the alternative splicing of exon 4. A greater expression of the three isoforms (A, B, and C), along with low levels of the NKp30 ligand B7H6, has been reported as a positive prognostic factor in different cancer types. Here, in patients with cervical cancer and precursor lesions, we report an altered immune-phenotype, characterized by non-fitness markers, that correlated with increased disease stage, from CIN 1 to FIGO IV. While overall NK cell numbers increased, loss of NKp30 <superscript>+</superscript> NK cells, especially in the CD56 <superscript>dim</superscript> subpopulation, was found. Perforin levels were decreased in these cells. Decreased expression of the NKp30 C isoform and overexpression of soluble B7H6 was found in cervical cancer patients when compared against healthy subjects. PBMCs from healthy subjects downregulated NKp30 isoforms after co-culture with B7H6-expressing tumour cells. Taken together, these findings describe a unique down-modulation or non-fitness status of the immune response in cervical cancer, the understanding of which will be important for the design of novel immunotherapies against this disease.<br /> (© 2022 John Wiley & Sons Ltd.)

Details

Language :
English
ISSN :
1365-2567
Volume :
168
Issue :
3
Database :
MEDLINE
Journal :
Immunology
Publication Type :
Academic Journal
Accession number :
36271832
Full Text :
https://doi.org/10.1111/imm.13593